The TARGETED SOLUTIONS FOR RENAL THERAPY brand, founded in 2005 (United States), from 15 sister brands and 4472 competing brands. The TARGETED SOLUTIONS FOR RENAL THERAPY brand is owned by Angiodynamics, a company listed in New York. TARGETED SOLUTIONS FOR RENAL THERAPY is part of the Medical Devices & Instruments activity sector.
Share price and profitability of the share Angiodynamics (TARGETED SOLUTIONS FOR RENAL THERAPY)
Buy Angiodynamics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Angiodynamics
(TARGETED SOLUTIONS FOR RENAL THERAPY)
over 5 years*
USD 1.65
Stock market history Angiodynamics (TARGETED SOLUTIONS FOR RENAL THERAPY)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
